<DOC>
	<DOCNO>NCT02826057</DOCNO>
	<brief_summary>This study include comatose survivor out-of-hospital cardiac arrest treat 24 hour 48 hour target temperature management . The overall aim evaluate importance plasma complement protein concentration patient resuscitate out-of-hospital cardiac arrest treat 24 hour 48 hour target temperature management . The specific aim evaluate : - concentration plasma lectin pathway protein first , second third day cardiac arrest - relation concentration plasma lectin pathway protein mortality - prolong targeted temperature management influence concentration plasma lectin pathway proteins This study sub-study trial entitle : `` Time-differentiated targeted temperature management ( TTH48 ) ( ClinicalTrials.gov Identifier : NCT01689077 ) '' The following Complement Lectin Pathway proteins measure : Mannan-Binding-Lectin , M-ficolin , H-ficolin , CL-L1 , MASP-1 , MASP-2 , MASP-3 , MAp19 MAp44 .</brief_summary>
	<brief_title>The Complement Lectin Pathway After Cardiac Arrest</brief_title>
	<detailed_description />
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
	<mesh_term>Complement System Proteins</mesh_term>
	<criteria>OutofHospital Cardiac Arrest presume cardiac cause Return spontaneous circulation ( ROSC ) Glasgow Coma Score &lt; 8 Age &gt; 18 year &lt; 80 year &gt; 60 minute circulatory collapse ROSC Time interval &gt; 4 hour cardiac arrest initiation target temperature management Terminal illness Coagulation disorder Unwitnessed asystolia Cerebral performance category 34 cardiac arrest Severe persistent cardiogenic shock Pregnancy Persistent cardiogenic shock ( systolic bloodpressure &lt; 80 despite inotropic treatment ) New apoplexy cerebral hemorrhage Lack consent relatives Lack consent general practitioner Lack consent patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>